ENEAST: Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Sponsor
University Hospital, Angers (Other)
Overall Status
Unknown status
CT.gov ID
NCT03812913
Collaborator
University of Angers, Angers (Other)
70
33

Study Details

Study Description

Brief Summary

Turner syndrome (TS) is a rare chromosomal disorder characterized by partial or complete loss of one of the X chromosomes that affects about one in every 2000 female babies born. These young patients described difficulties making friends, understanding others' emotions and intentions, and controlling their own emotions. Difficulties in these domains could led to social withdrawal, to reduced social skills and could have a significant impact on self esteem and mental health as well as on long-term academic and social functioning in affected individuals. The purpose of this project is to identify functional and dysfunctional cognitive and socio-cognitive abilities in these young patients which could account social difficulties described by some of them and their family. To this end, 35 girls with TS and 35 girls with isolated growth hormone deficiency and normal cerebral MRI will be recruited. Subjects will be 7 to 16 years and 11 months of age. Socio-cognitive and cognitive functions will be assessed with neuropsychological and experimental tasks. Questionnaires completed by patient, parents or teacher, will evaluate social and behavioral functioning.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: psychological evaluation

Detailed Description

Cross-sectional study (2 groups : Turner syndrome, isolated growth hormone deficiency), not randomized, controlled, associating several specialized centers in endocrine diseases.

The pediatric endocrinologist of the participating centers will contact parents of each patient or voluntary child/adolescent in order to inform them of the study.

The visit of inclusion will take place in the participant center during a routine monitoring visit.

The first visit (V1) will take place immediately after the visit of inclusion in order to avoid a specific displacement for the needs for the study. The second visit (V2) will take place in participant's home. Each visit (V1 and V2) will last half-day. The period between V1 and V2 will be three months maximum.

The visits V1 and V2 will be carried out by neuropsychologists of the Laboratoire de Psychologie des Pays de la Loire (LPPL - EA 4638).

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Anticipated Study Start Date :
Feb 1, 2019
Anticipated Primary Completion Date :
May 1, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Turner Syndrome

35 girls with Turner syndrome (except patients with part of a Y chromosome in their karyotype and r(X) cases). age : 7 years -16 years and 11 months. Psychological evaluation of cognition, social cognition and affective cognition

Behavioral: psychological evaluation
Neuropsychological and experimental tasks will assess cognitive and socio-cognitive functions. Questionnaires will assess psychoaffective aspects (depression, anxiety, self-esteem), and social and behavioral functioning.

isolated GHD

35 girls with isolated Growth Hormone Deficiency (GHD). age : 7 years -16 years and 11 months. Psychological evaluation of cognition, social cognition and affective cognition

Behavioral: psychological evaluation
Neuropsychological and experimental tasks will assess cognitive and socio-cognitive functions. Questionnaires will assess psychoaffective aspects (depression, anxiety, self-esteem), and social and behavioral functioning.

Outcome Measures

Primary Outcome Measures

  1. Wechsler Intelligence Scale for Children (WISC-V) [3 months]

    intelligence scale.

  2. Cognitive theory of mind first order [3 months]

    First order theory of mind tasks (Baron-Cohen et al., 1985)

  3. Cognitive theory of mind second order [3 months]

    second-order theory of mind tasks Perner & Wimmer, 1983)

  4. Cognitive theory of mind advanced [3 months]

    advanced theory of mind tasks (Happé, 1994)

  5. Cognitive theory of mind : humor [3 months]

    Humor understanding task

  6. Affective theory of mind : faux pas [3 months]

    Faux pas recognition test (Baron Cohen et al., 1999)

  7. Affective theory of mind : first order [3 months]

    First-order affective theory of mind tasks

  8. Affective theory of mind : second order [3 months]

    Second-order affective theory of mind tasks

  9. Affective theory of mind : emotional inference [3 months]

    Emotional inference for context test

  10. Emotional valence recognition : valence [3 months]

    Emotional valence rating from visual scenes

  11. Facial emotion recogniton [3 months]

    Facial emotion recognition task

  12. Vocal emotion recognition [3 months]

    Emotional prosody recognition task

  13. Emotional regulation [3 months]

    Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA)

  14. Alexithymia [3 months]

    Questionnaire d'alexithymie chez l'enfant (QAE)

  15. Empathy [3 months]

    Interpersonal Reactivity Index (IRI)

  16. Oral Language comprehension abilities 1 [3 months]

    Comprehension of Instructions (NEPSY-II, Korkman et al., 2012)

  17. Oral Language comprehension abilities 2 [3 months]

    Verbal comprehension index (from WISC-V)

  18. Visual and visual-spatial abilities:1 [3 months]

    Arrows subtest (NEPSY-II - Korkman et al., 2012),

  19. Visual and visual-spatial abilities:2 [3 months]

    Picture Puzzles subtest (NEPSY-II - Korkman et al., 2012)

  20. Visual and visual-spatial abilities:3 [3 months]

    Benton Facial Recognition Test (Benton et al., 1983)

  21. Executive abilities-Verbal Working memory 1 [3 months]

    Verbal information updating task

  22. Executive abilities-Visuo-Spatial Working memory 2 [3 months]

    Visuo-spatial information updating task

  23. Executive abilities-Inhibition 1 [3 months]

    Stroop test.

  24. Executive abilities-Inhibition 2 [3 months]

    Tapping test

  25. Executive abilities-Inhibition 3 [3 months]

    non-verbal cancellation task

  26. Executive abilities-Cognitive Flexibility 1 [3 months]

    Verbal fluency task (NEPSY-II Korkman et al., 2012)

  27. Executive abilities-Cognitive Flexibility 2 [3 months]

    Modified Wisconsin Card Sorting Test for children

  28. Executive abilities-Cognitive Flexibility 3 [3 months]

    Trail Making Test

  29. Executive abilities-Higher-order executive functions 1 [3 months]

    script generation task

  30. Executive abilities-Higher-order executive functions 2 [3 months]

    Rey Complex Figure Test : Copy

  31. Executive abilities in daily life [3 months]

    Behavioral Rating Inventory of Executive Functions

  32. Self Esteem [3 months]

    Rosenberg self-esteem scale (1965).

  33. Depression inventory [3 months]

    Depression: Children's Depression Inventory (Kovacks & Beck, 1977).

  34. Anxiety inventory [3 months]

    Revised Children's Manifest Anxiety Scale (Reynolds & Richmond, 1999).

  35. Social desirability [3 months]

    Children's Social Desirability Scale (Crandall et al., 1965)

  36. social adjustment 1 [3 months]

    Conners' Parent Rating Scale-Revised: Short Form (Conners, 1997)

  37. social adjustment 2 [3 months]

    Conners' Teacher Rating Scale-Revised: Short Form (Conners, 1997)

  38. behavioral adjustment [3 months]

    Child Behavior Checklist (Achenbach, 1991).

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 16 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No

INCLUSION CRITERIA

Turner syndrome group :
  • girls with diagnosed Turner syndrome.
Isolated GHD group :
  • girls with diagnosed isolated growth hormone deficiency
All participants :
  • age between 7 years to 16 years and 11 months.

  • informed consent signed by the participant and her parents (or her legal representatives)

  • being registered in the national social security system

EXCLUSION CRITERIA :
Turner syndrome group :
  • patients with chronic pathology other than Turner syndrome.

  • karyotype : part of a Y chromosome and r(X) cases.

  • medical treatment other than those usually prescribed in patients with Turner syndrome.

Isolated GHD group :
  • patients with chronic pathology other than isolated growth hormone deficiency.

  • medical treatment other than those usually prescribed in patients with isolated growth hormone deficiency.

All participants :
  • diagnosed intellectual disability (IQ<70) or intellectual giftedness

  • history of acquired brain injury

  • sensory disturbances (auditory or visual) incompatible with the achievement of neuropsychological tasks.

  • insufficient French language proficiency

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Angers
  • University of Angers, Angers

Investigators

  • Principal Investigator: Régis Coutant, MD PhD, UH Angers

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT03812913
Other Study ID Numbers:
  • 2018-A01478-47
First Posted:
Jan 23, 2019
Last Update Posted:
Jan 23, 2019
Last Verified:
Jan 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Angers
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 23, 2019